Research status and funding trends of lung cancer biomarkers

被引：21

作者：

Cui Li ^{[1
]}

Wei Hong ^{[1
]}

机构：

[1] Natl Nat Sci Fdn China, Dept Hlth Sci, Beijing 100083, Peoples R China

来源：

JOURNAL OF THORACIC DISEASE | 2013年 / 5卷 / 05期

关键词：

Lung cancer; molecular biomarker; research grants; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MESSENGER-RNA; GROWTH-FACTOR; EXPRESSION; DIAGNOSIS; SURVIVAL; GENE; METHYLATION; SERUM;

D O I：

10.3978/j.issn.2072-1439.2013.10.10

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. At present, research of early diagnosis, treatment, prognosis, and metastasis associated biomarkers is most active. This article reviewed the research status of lung cancer biomarkers and analyzed the funding situation in the field of lung cancer markers in recent 10 years in China and abroad, to provide a reference for the future basic and clinical translational research of lung cancer biomarkers.

引用

页码：698 / 705

页数：8

共 58 条

[1] Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients [J].

Bacchi, Carlos E. ;

Ciol, Heloisa ;

Queiroga, Eduardo M. ;

Benine, Lucimara C. ;

Silva, Luciana H. ;

Ojopi, Elida B. .

CLINICS, 2012, 67 (05) :419-424

[2]

Balgkouranidou I, 2013, BIOMARK MED, V7, P49, DOI [10.2217/BMM.12.111, 10.2217/bmm.12.111]

[3] Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study [J].

Chang, Alex ;

Parikh, Purvish ;

Thongprasert, Sumitra ;

Tan, Eng Huat ;

Perng, Reury- Perng ;

Ganzon, Domingo ;

Yang, Chih-Hsin ;

Tsao, Chao-Jung ;

Watkins, Claire ;

Botwood, Nick ;

Thatcher, Nick .

JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) :847-855

[4] Biomarkers and transcriptome profiling of lung cancer [J].

Chen, Hsuan-Yu ;

Yu, Sung-Liang ;

Li, Ker-Chau ;

Yang, Pan-Chyr .

RESPIROLOGY, 2012, 17 (04) :620-626

[5]

Chen Wan-qing, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P378

[6] Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis [J].

Cho, W. C. S. ;

Yip, T. T. ;

Cheng, W. W. ;

Au, J. S. K. .

BRITISH JOURNAL OF CANCER, 2010, 102 (12) :1731-1735

[7] Contribution of oncoproteomics to cancer biomarker discovery [J].

Cho, William C. S. .

MOLECULAR CANCER, 2007, 6 (1)

[8] Molecular diagnostics for monitoring and predicting therapeutic effect in cancer [J].

Cho, William C. S. .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (01) :9-12

[9] Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population [J].

Dong, Jing ;

Hu, Zhibin ;

Wu, Chen ;

Guo, Huan ;

Zhou, Baosen ;

Lv, Jiachun ;

Lu, Daru ;

Chen, Kexin ;

Shi, Yongyong ;

Chu, Minjie ;

Wang, Cheng ;

Zhang, Ruyang ;

Dai, Juncheng ;

Jiang, Yue ;

Cao, Songyu ;

Qin, Zhenzhen ;

Yu, Dianke ;

Ma, Hongxia ;

Jin, Guangfu ;

Gong, Jianhang ;

Sun, Chongqi ;

Zhao, Xueying ;

Yin, Zhihua ;

Yang, Lei ;

Li, Zhiqiang ;

Deng, Qifei ;

Wang, Jiucun ;

Wu, Wei ;

Zheng, Hong ;

Zhou, Guoquan ;

Chen, Hongyan ;

Guan, Peng ;

Peng, Zhihang ;

Chen, Yijiang ;

Shu, Yongqian ;

Xu, Lin ;

Liu, Xiangyang ;

Liu, Li ;

Xu, Pin ;

Han, Baohui ;

Bai, Chunxue ;

Zhao, Yuxia ;

Zhang, Haibo ;

Yan, Ying ;

Amos, Christopher I. ;

Chen, Feng ;

Tan, Wen ;

Jin, Li ;

Wu, Tangchun ;

Lin, Dongxin .

NATURE GENETICS, 2012, 44 (08) :895-+

[10] Crizotinib in the treatment of non-small-cell lung cancer [J].

Forde, Patrick M. ;

Rudin, Charles M. .

EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) :1195-1201

← 1 2 3 4 5 6 →